Literature DB >> 21846839

Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).

Megan Roth1, Juan J Araya, Barbara N Timmermann, Bruno Hagenbuch.   

Abstract

Organic anion-transporting polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) are liver-specific transporters that mediate the uptake of a broad range of drugs into hepatocytes, including statins, antibiotics, and many anticancer drugs. Compounds that alter transport by one or both of these OATPs could potentially be used to target drugs to hepatocytes or improve the bioavailability of drugs that are cleared by the liver. In this study, we applied a bioassay-guided isolation approach to identify such compounds from the organic extract of Rollinia emarginata Schlecht (Annonaceae). Fractions of the plant extract were screened for effects on OATP1B1- and OATP1B3-mediated transport of the model substrates estradiol-17β-glucuronide and estrone-3-sulfate. We isolated three compounds, ursolic acid, oleanolic acid, and 8-trans-p-coumaroyloxy-α-terpineol, which inhibited estradiol-17β-glucuronide uptake by OATP1B1 but not OATP1B3. In addition, a rare compound, quercetin 3-O-α-l-arabinopyranosyl(1→2) α-L-rhamnopyranoside, was identified that had distinct effects on each OATP. OATP1B1 was strongly inhibited, as was OATP1B3-mediated transport of estradiol-17β-glucuronide. However, OATP1B3-mediated uptake of estrone-3-sulfate was stimulated 4- to 5-fold. Kinetic analysis of this stimulation revealed that the apparent affinity for estrone-3-sulfate was increased (decreased K(m)), whereas the maximal rate of transport (V(max)) was significantly reduced. These results demonstrate a mechanism through which the hepatic uptake of drug OATP substrates could be stimulated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846839      PMCID: PMC3199999          DOI: 10.1124/jpet.111.184564

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata.

Authors:  Michelle F Muzitano; Luzineide W Tinoco; Catherine Guette; Carlos R Kaiser; Bartira Rossi-Bergmann; Sônia S Costa
Journal:  Phytochemistry       Date:  2006-08-23       Impact factor: 4.072

2.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

3.  Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

Authors:  Jae-Yong Chung; Joo-Youn Cho; Kyung-Sang Yu; Jung-Ryul Kim; Dal-Seok Oh; Hye-Ryung Jung; Kyoung-Soo Lim; Ki-Ho Moon; Sang-Goo Shin; In-Jin Jang
Journal:  Clin Pharmacol Ther       Date:  2005-10       Impact factor: 6.875

Review 4.  Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.

Authors:  B Hagenbuch; C Gui
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 5.  Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides.

Authors:  David J Greenblatt
Journal:  J Clin Pharmacol       Date:  2009-09-29       Impact factor: 3.126

6.  Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.

Authors:  Yohei Nishizato; Ichiro Ieiri; Hiroshi Suzuki; Miyuki Kimura; Kiyoshi Kawabata; Takeshi Hirota; Hiroshi Takane; Shin Irie; Hiroyuki Kusuhara; Yoko Urasaki; Akinori Urae; Shun Higuchi; Kenji Otsubo; Yuichi Sugiyama
Journal:  Clin Pharmacol Ther       Date:  2003-06       Impact factor: 6.875

7.  Bioactive constituents from Rollinia emarginata (Annonaceae).

Authors:  Olga Alvarez Colom; Susana Popich; Alicia Bardon
Journal:  Nat Prod Res       Date:  2007-03       Impact factor: 2.861

8.  Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.

Authors:  Akinobu Hamada; Tristan Sissung; Douglas K Price; Romano Danesi; Cindy H Chau; Nima Sharifi; David Venzon; Kenji Maeda; Keisuke Nagao; Alex Sparreboom; Hiroaki Mitsuya; William L Dahut; William D Figg
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

9.  Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

Authors:  C M F Kruijtzer; J H Beijnen; H Rosing; W W ten Bokkel Huinink; M Schot; R C Jewell; E M Paul; J H M Schellens
Journal:  J Clin Oncol       Date:  2002-07-01       Impact factor: 44.544

10.  Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

Authors:  Iouri Bachmakov; Hartmut Glaeser; Martin F Fromm; Jörg König
Journal:  Diabetes       Date:  2008-02-26       Impact factor: 9.461

View more
  22 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

3.  Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.

Authors:  Marta Popovic; Roko Zaja; Karl Fent; Tvrtko Smital
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

4.  Gly45 and Phe555 in Transmembrane Domains 1 and 10 Are Critical for the Activation of Organic Anion Transporting Polypeptide 1B3 by Epigallocatechin Gallate.

Authors:  Mei Yue; Jingjie Yang; Meng Jin; Brianna Steiert; Yiqun Xiang; Hongjian Zhang; Bruno Hagenbuch; Chunshan Gui
Journal:  J Agric Food Chem       Date:  2019-08-06       Impact factor: 5.279

5.  A hybrid model to evaluate the impact of active uptake transport on hepatic distribution of atorvastatin in rats.

Authors:  Priyanka Kulkarni; Ken Korzekwa; Swati Nagar
Journal:  Xenobiotica       Date:  2019-10-01       Impact factor: 1.908

6.  Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (Camellia sinensis) Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo Extrapolation.

Authors:  Dan-Dan Tian; Joshua J Kellogg; Neşe Okut; Nicholas H Oberlies; Nadja B Cech; Danny D Shen; Jeannine S McCune; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

7.  Screening of natural compounds as activators of the keap1-nrf2 pathway.

Authors:  Kai C Wu; Peter R McDonald; Jie Liu; Curtis D Klaassen
Journal:  Planta Med       Date:  2013-12-05       Impact factor: 3.352

8.  Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.

Authors:  Yuchen Zhang; Amanda Hays; Alexander Noblett; Mahendra Thapa; Duy H Hua; Bruno Hagenbuch
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

Review 9.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

10.  A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect".

Authors:  Christina S Won; Tian Lan; Karen M Vandermolen; Paul A Dawson; Nicholas H Oberlies; Wilbur W Widmer; Yolanda V Scarlett; Mary F Paine
Journal:  J Clin Pharmacol       Date:  2013-07-23       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.